Adalta

Adalta Gross Margin

The Gross Margin of Adalta (1AD.AX) as of Oct 16, 2026 is 67.58 %. In the previous year, Gross Margin was 86.77 % — a change of -22.12% (lower).

Gross Margin

67.58 %

YoY

-22.12%

Last updated:

Gross Margin of Adalta is 2025 67.58 % . Gross Margin of Adalta was 2024 86.77 % . It decreases by -22.12% lower compared to the previous year.

Adalta's gross margin stands at 67.6%, up from 21.3% several years earlier.

The Adalta Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
99.84 AUD
Jan 1, 2019
99.08 AUD
Jan 1, 2020
-166.28 AUD
Jan 1, 2021
21.27 AUD
Jan 1, 2022
35.86 AUD
Jan 1, 2023
99.14 AUD
Jan 1, 2024
86.77 AUD
Jan 1, 2025
67.58 AUD
The Adalta Gross Margin history
YEARGross MarginYoY
67.58 %-22.12%
86.77 %-12.47%
99.14 %+176.48%
35.86 %+68.56%
21.27 %-112.79%
-166.28 %-267.82%
99.08 %-0.76%
99.84 %+0.15%
99.70 %-0.21%
99.91 %-197.70%
-102.26 %-12.00%
-116.20 %+24,112.44%
-0.48 %-64.71%
-1.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adalta Stock analysis

What does Adalta do? Adalta Ltd is a biotechnology company based in Melbourne, Australia, operating within the Health Care sector. The company focuses on discovering, developing, and commercializing protein-based therapeutics, leveraging its i-body platform technology. Adalta has five active development programs spanning from discovery to Phase II clinical trials, targeting applications in inflammation/fibrosis and immuno-oncology. Its lead product, AD-214, is an antibody therapeutic designed for the treatment of fibrotic diseases, including lung fibrosis such as Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD), as well as kidney fibrosis, eye fibrosis, and certain cancers. The company also develops i-body enabled PET (i-PET) imaging agents for use in immuno-oncology applications. Additionally, Adalta evaluates several CXCR4 i-bodies. The company went public on August 22, 2016, with its ticker listed as 1AD.AX and ISIN AU0000001AD2. Adalta's website is https://adalta.com.au/. Adalta is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adalta stock

Gross Margin of Adalta is 67.58 % in 2025.

Gross Margin of Adalta changed from 86.77 % to 67.58 %, representing a -22.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Adalta since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Adalta with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Adalta

All Key Metrics — Adalta